
Healthify has merged with New York-based Berry Street in an all-stock deal, becoming a US company with its India business now a subsidiary. The merged entity will be led by co-CEOs Tushar Vashisht of Healthify and Noah Kotlove of Berry Street. Financial details have not been disclosed.

Healthify's AI platform will combine with Berry Street's insurance-covered clinical nutrition network. In the US, Healthify's direct-to-consumer operations have ended, Berry Street will handle the US market. Healthify will now focus on India, including B2B partnerships with pharma companies and insurers, and is exploring an offline-to-online centre strategy. A US public offering is possible in at least 24 months.
The coverage is uniform and straight, all three outlets report the Healthify-Berry Street merger facts without discernible slant. Livemint leads with the structural change (Healthify becomes a US company, India a subsidiary) and includes the founder's candid reasoning about insurance gaps, plus the pivot to B2B and physical centres. Inc42 leads with the 'AI-powered insurance-covered platform' framing and lists investor history. Barandbench simply names the legal teams. No outlet challenges the founder's narrative or investigates risks. The balanced take: this is a carefully negotiated reverse-merger that gives Healthify US insurance access while Berry Street gets AI capability, the stated 24-month timeline for a US IPO and the shelved India listing are the concrete items to track.
Coverage: 3 sources, 3 neutral
Sources (3): livemint.com (neutral report), inc42.com (neutral report), barandbench.com (neutral report)
This brief was synthesised by AI from the 3 sources linked above, so one read covers every framing they carry. Methodology and corrections.
Updated: this story now draws on 3 sources.